Cargando…
MON-653 The Effects of DPP IV Inhibitor on Glycemic Variability in Type 2 Diabetic Patients Treated with Twice Daily Premixed Human Insulin
Glycemic variability (GV) is emerging as an exciting therapeutic target for diabetes mellitus (DM) with recent evidences showing association of GV with hypoglycemia risk as well as chronic complications.(1,2) Twice daily human premixed insulin is commonly used in developing countries and Asia for tr...
Autores principales: | Tan, Florence Hui Sieng, Tong, Chin Voon, Kuan, Yueh Chien, Lau, Bik Kui, Loh, Huai Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209463/ http://dx.doi.org/10.1210/jendso/bvaa046.783 |
Ejemplares similares
-
The Effect of DPP4 Inhibitor on Glycemic Variability in Patients with Type 2 Diabetes treated with twice-daily Premixed Human Insulin*
por: Tan, Florence Hui Sieng, et al.
Publicado: (2021) -
MON-697 Necrotising Fasciitis- Importance of Glycemic Control
por: Kasireddy, Amulya Reddy, et al.
Publicado: (2020) -
MON-173 Vitamin D And Glycemic Control In Type 2 Diabetes
por: Jadoon, Nauman, et al.
Publicado: (2019) -
MON-632 The Effects of a High Intensity Glycemic Program on Weight and BMI
por: Guzman, Heidi, et al.
Publicado: (2020) -
SUN-653 Bypassing Skeletal Muscle Lipid Handling Deficiencies as a Therapy for Metabolic Disease
por: Fan, Liyan, et al.
Publicado: (2020)